Cat.#: ACPP-1258
| Despition | Pannexin 1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1099 | Synthetic Nanodisc Human Adenosine Receptor A2a Protein (AC1099) | 10 µg | inquiry |
| ACPP-1223 | PAX8 Blocking Peptide (AC1223) | 250 µg | inquiry |
| ACPP-1243 | ELOVL4 Blocking Peptide (AC1243) | 250 µg | inquiry |
| ACPP-1204 | P2Y1 Blocking Peptide (AC1204) | 250 µg | inquiry |
| ACPP-1745 | Mouse Acrp30 Protein, His (AC1745) | 5 µg | inquiry |
| ACPP-1154 | Recombinant Human FGF19 Protein (6×His Tag) (AC1154) | 50 µg | inquiry |
| ACPP-1226 | PDE7A Blocking Peptide (AC1226) | 250 µg | inquiry |
| ACPP-1044 | Recombinant Human RAGE Protein (6×His Tag) (AC1044) | 50 µg | inquiry |
| ACPP-1592 | Human CRYAB Protein (AC1592) | 20 µg | inquiry |
| ACPP-1732 | Human CHRNA6 Protein (AC1732) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.